X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
10
PharmaCompass offers a list of Sodium Iodide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Iodide manufacturer or Sodium Iodide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Iodide manufacturer or Sodium Iodide supplier.
PharmaCompass also assists you with knowing the Sodium Iodide API Price utilized in the formulation of products. Sodium Iodide API Price is not always fixed or binding as the Sodium Iodide Price is obtained through a variety of data sources. The Sodium Iodide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 03129_SIAL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 03129_SIAL, including repackagers and relabelers. The FDA regulates 03129_SIAL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 03129_SIAL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 03129_SIAL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 03129_SIAL supplier is an individual or a company that provides 03129_SIAL active pharmaceutical ingredient (API) or 03129_SIAL finished formulations upon request. The 03129_SIAL suppliers may include 03129_SIAL API manufacturers, exporters, distributors and traders.
click here to find a list of 03129_SIAL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 03129_SIAL DMF (Drug Master File) is a document detailing the whole manufacturing process of 03129_SIAL active pharmaceutical ingredient (API) in detail. Different forms of 03129_SIAL DMFs exist exist since differing nations have different regulations, such as 03129_SIAL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 03129_SIAL DMF submitted to regulatory agencies in the US is known as a USDMF. 03129_SIAL USDMF includes data on 03129_SIAL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 03129_SIAL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 03129_SIAL suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 03129_SIAL Drug Master File in Japan (03129_SIAL JDMF) empowers 03129_SIAL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 03129_SIAL JDMF during the approval evaluation for pharmaceutical products. At the time of 03129_SIAL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 03129_SIAL suppliers with JDMF on PharmaCompass.
A 03129_SIAL written confirmation (03129_SIAL WC) is an official document issued by a regulatory agency to a 03129_SIAL manufacturer, verifying that the manufacturing facility of a 03129_SIAL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 03129_SIAL APIs or 03129_SIAL finished pharmaceutical products to another nation, regulatory agencies frequently require a 03129_SIAL WC (written confirmation) as part of the regulatory process.
click here to find a list of 03129_SIAL suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 03129_SIAL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 03129_SIAL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 03129_SIAL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 03129_SIAL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 03129_SIAL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 03129_SIAL suppliers with NDC on PharmaCompass.
03129_SIAL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 03129_SIAL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 03129_SIAL GMP manufacturer or 03129_SIAL GMP API supplier for your needs.
A 03129_SIAL CoA (Certificate of Analysis) is a formal document that attests to 03129_SIAL's compliance with 03129_SIAL specifications and serves as a tool for batch-level quality control.
03129_SIAL CoA mostly includes findings from lab analyses of a specific batch. For each 03129_SIAL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
03129_SIAL may be tested according to a variety of international standards, such as European Pharmacopoeia (03129_SIAL EP), 03129_SIAL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (03129_SIAL USP).
Market Place
